1905 Audubon Ct.
Spokane, WA 99224

07-24-2018 – ETBI – EastGate Biotech Provides Update on Investment From Genluiching Mining Corporation

EastGate to Receive the First Non-dilutive Investment Tranch from the Total Funding up to $5 million USD as per the Terms of the Definitive Agreement WEST CALDWELL, NJ and TORONTO, ON / ACCESSWIRE / July 24, 2018 /Ā EastGate Biotech Corp. (OTC PINK: ETBI), a pharmaceutical company that focuses on innovative technological developments specifically in insulin drug delivery for the treatment of type 2 diabetes, announced that it is to receive the first tranch of the investment from Genluiching Mining Corporation as per the definitive agreement signed in April. As per the previously announced executed Definitive Agreement, Genluiching Mining will invest...

Read More

03-01-2018 – ETBI – Eastgate Biotech Provides Corporate Update

WEST CALDWELL, NJ and TORONTO, ON / ACCESSWIRE / March 1, 2018 /Ā EastGate Biotech Corp. (OTC PINK: ETBI), an emerging pharmaceutical company that focuses on innovative pharmaceutical developments and produces and distributes innovative and healthy nutraceuticals based on natural therapies has announced today its corporate update. EastGate Biotech is pleased to provide its shareholders with the following corporate update: The Company's strategic moves over the past year to improve its underlying operations were part of a corporate vision to be a "disrupter" in the drug delivery sector targeting unmet medical needs. As a company, we collectively agreed that drug development...

Read More